MSB 2.70% 95.0¢ mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-336

  1. 7,820 Posts.
    lightbulb Created with Sketch. 1344
    Dolce, I don't disagree there is potential in stem cell therapies.

    But if you don't learn from this and instead double down and blame the FDA and big pharma you might want to consider staying away from investing in biotech.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.